Development of an Accessible and Scalable Quantitative Polymerase Chain Reaction Assay for Monkeypox Virus Detection

J Infect Dis. 2023 Apr 26;227(9):1084-1087. doi: 10.1093/infdis/jiac414.

Abstract

During the 2022 monkeypox (MPX) outbreak, testing has been limited and results delayed, allowing ongoing transmission. Gold-standard quantitative polymerase chain reaction (qPCR) diagnostics are difficult to obtain. This research adapted the June 2022 CDC MPX qPCR assay for broad implementation. Validated using MPX stocks in a matrix with multiple sample types, MPX was detected with cycle threshold (Ct) values 17.46-35.59 and titer equivalents 8.01 × 106 to 2.45 × 100 plaque-forming unit (PFU)/mL. The detection limit was 3.59 PFU/mL. Sensitivity and specificity were both 100%. This qPCR assay can be quickly and broadly implemented in research and public health laboratories to increase diagnostic capacity amid the growing MPX outbreak.

Keywords: PCR; diagnostics; emerging infectious disease; global health; monkeypox; outbreak response; qPCR assay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diagnostic Tests, Routine* / methods
  • Humans
  • Monkeypox virus / genetics
  • Mpox (monkeypox)* / diagnosis
  • Polymerase Chain Reaction*
  • Reproducibility of Results
  • Sensitivity and Specificity